Movement Alert|METIS TECHBIO-P Falls 5.17% in Regular Trading, Profit-Taking Continues After 40%-Plus Surge on Stock Connect Inclusion

Market Focus
Sep 11

On September 11, METIS TECHBIO-P fell 5.17% in regular trading, trading at HK$16.40, with turnover of HK$15.81 million. The stock extended its pullback for a second consecutive session as short-term profit-taking intensified.

Since its formal inclusion in the Stock Connect eligible securities list on September 7, METIS TECHBIO-P had accumulated gains exceeding 40% within just three trading days, driven by unlocked southbound capital access and a strategic cooperation agreement with Greenleaf Pharmaceutical on AI-powered drug delivery. The rapid run-up created significant short-term profit overhang, with the stock already retreating over 5% in the prior session.

The broader biotechnology sector continued to trade weak, adding further downside pressure. Within the sector, INNOVENT BIO fell 1.75%, AKESO declined 2.19%, BEONE MEDICINES dropped 1.84%, and HBM HOLDINGS-B slid 4.44%, reflecting subdued sector-wide sentiment. Market participants appear to be locking in gains from the post-inclusion rally amid a risk-off tone across the biotech space.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10